Post-IPO Equity Medical Companies

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cheelcare develops robotic mobility devices and accessories for people with disabilities.

VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation.

Targovax develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.

Principal Technologies is a Canadian business that invests in healthcare technologies.

Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

Freedom from glasses and contact lenses is a goal that is now a reality.

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Bluejay Diagnostics is a manufacturing company

Polaryx Therapeutics is a biopharmaceutical company that provides molecule therapeutics development and clinical trial services.

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies.

NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.

Cantargia develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.

Optimi Health is a supplier of GMP psychedelic compounds.

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

QT Imaging is a scanning center that provides breast imaging by tomographic transmission ultrasound for patients.

Zentek is a nanomaterials technology company that develops graphene-based technologies.

Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.